Bristol Myers Squibb BMY
NYSE BMY
$61.54 +2.71 (+4.61%)
As of: Oct 20, 2026 · 2:37 PM EDT

Bristol Myers Squibb (BMY) Non-Current Debt (2009 - 2026)

Updated

Bristol Myers Squibb's Non-Current Debt came in at $42.09 billion for Q2 2026, down 5.3% from $44.47 billion a year earlier and down 0.1% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Non-Current Debt (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb's Non-Current Debt was $42.85 billion, down 10.0% from FY2024.

  • Non-Current Debt carries a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
  • Going back by year, Non-Current Debt was $47.6 billion in FY2024 (+29.9%), $36.65 billion in FY2023 (+4.6%), $35.06 billion in FY2022 (-11.5%) and $39.61 billion in FY2021 (-18.1%).
  • The Q2 2026 figure represents the lowest quarterly Non-Current Debt since Q4 2023.
  • Year-over-year, Non-Current Debt has declined for six consecutive quarters, with growth averaging 4.1% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Debt over five years came in Q3 2024 (growth of 51.5%), and the weakest in Q4 2021 (a decline of 18.1%).
  • Business Quant data shows BMY's Non-Current Debt at $42.15 billion (Q1 2026), $42.85 billion (Q4 2025) and $44.47 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,147.31 Bn 1,115.89 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.29 Bn 542.81 Bn 17.26 Bn 37.34 Bn
3 AbbVie 511.65 Bn 484.76 Bn 12.70 Bn 62.48 Bn
4 Merck 365.71 Bn 320.09 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 23.68 Bn
7 Amgen 234.89 Bn 190.29 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.41 Bn 168.60 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.08 Bn 118.73 Bn 10.94 Bn 60.50 Bn
10 Bristol Myers Squibb 125.57 Bn 76.84 Bn 9.25 Bn 42.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.09 Bn
Mar 31, 2026 42.15 Bn
Dec 31, 2025 42.85 Bn
Sep 30, 2025 44.47 Bn
Jun 30, 2025 44.47 Bn
Mar 31, 2025 46.16 Bn
Dec 31, 2024 47.60 Bn
Sep 30, 2024 48.67 Bn
Jun 30, 2024 48.86 Bn
Mar 31, 2024 49.49 Bn
Dec 31, 2023 36.65 Bn
Sep 30, 2023 32.14 Bn
Jun 30, 2023 34.66 Bn
Mar 31, 2023 35.08 Bn
Dec 31, 2022 35.06 Bn
Sep 30, 2022 36.97 Bn
Jun 30, 2022 37.11 Bn
Mar 31, 2022 37.45 Bn
Dec 31, 2021 39.61 Bn
Sep 30, 2021 39.68 Bn
API Access

Bristol Myers Squibb Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BMY&period=max&api_key=YOUR_API_KEY